| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $225K | — | -35.5% |
| SG&A Expense | $214K | — | +43.8% |
| Operating Income | -$1.9M | — | -275.2% |
| Pre-tax Income | -$2.1M | — | -52.8% |
| Net Income | -$2.1M | — | -52.8% |
| EPS (Basic) | -$0.02 | — | +0.0% |
| EPS (Diluted) | -$0.02 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $463K | -9.8% | — |
| Total Assets | $615K | -6.6% | +352.2% |
| Current Liabilities | $5.0M | +54.2% | +76.2% |
| Total Liabilities | $5.0M | +54.2% | +76.2% |
| Stockholders' Equity | -$4.4M | -69.6% | -62.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$239K | — | -42.6% |
| Investing Cash Flow | -$9K | — | — |
| Financing Cash Flow | $201K | — | +20.7% |